RxDoctor Payments Data
★ My doctorsLook up a doctor →

Suzanne Paige, APRN

Family · Lady Lake, FLNPI 1538649157

Payments from drug & device makers

$12,230in general payments, 2019–2025

Across 563 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Incyte Corporation$794
  • Pfizer$775
  • Johnson & Johnson$726
  • Novartis$703
  • Merck$623
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$11,90797%
  • Education$3233%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)50$1,144
Incyte Corporation36$794
Pfizer35$775
Johnson & Johnson33$726
Novartis40$703
Merck29$623
Seagen Inc.25$549
Eisai Inc.24$529
Sanofi22$512
E.r. Squibb & Sons, L.L.C.19$401
Astellas Pharma US Inc21$369
Amgen17$333
Daiichi Sankyo Inc.14$320
Regeneron Healthcare Solutions, Inc.12$306
Takeda Pharmaceuticals U.S.A., Inc.11$298
Bristol Myers Squibb8$212
Jazz Pharmaceuticals Inc.10$197
Array Biopharma Inc11$194
Gilead7$167
Genentech USA, Inc.9$158
Bayer7$154
Taiho Oncology, Inc.7$151
Pharmacosmos Therapeutics Inc.6$143
Sobi, Inc6$140
Servier Pharmaceuticals LLC7$136
AbbVie5$133
Lilly USA, LLC6$130
EMD Serono, Inc.5$102
AVEO Pharmaceuticals, Inc.5$98
Geron Corporation4$98
Stemline Therapeutics Inc.4$96
Puma Biotechnology, Inc.5$88
Agios Pharmaceuticals, Inc.4$85
Beigene USA, Inc.4$84
Octapharma USA, Inc.1$83
G1 Therapeutics, Inc.4$82
Genmab U.S., Inc.3$80
Mirati Therapeutics, Inc.3$75
Beone Medicines USA, Inc.3$72
Pharmaessentia USA Corporation3$72
Blueprint Medicines Corporation3$64
Myriad Genetic Laboratories, Inc.2$62
Pharmacyclics LLC, An Abbvie Company3$60
Iovance Biotherapeutics, Inc.3$54
Tolmar, Inc.2$52
Boehringer Ingelheim2$49
CTI Biopharma Corp.2$46
Recordati_rare_diseases_inc.2$39
Sun Pharmaceutical Industries Inc.1$39
Tersera Therapeutics LLC1$31
Pharmaand GmbH1$29
Kyowa Kirin, Inc.2$28
GSK1$27
ADC Therapeutics America, Inc.1$25
AMAG Pharmaceuticals, Inc.1$22
Morphosys, US Inc.1$22
Apellis Pharmaceuticals, Inc.1$21
Acrotech Biopharma Inc.1$20
Rigel Pharmaceuticals, Inc.1$20
Menarini Silicon Biosystems, Inc.1$18

How this compares

$12,230 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Medicare billing

Part B allowed, 2024
$28,099
Medicare patients
15
Services billed
2,007

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$681
Hydroxyurea16$605
Tramadol Hcl18$242
Anastrozole16$217
Zolpidem Tartrate15$214

Paid to pharmacies, not to this prescriber.

Other family in Lady Lake

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →